Author

Huijuan Yang

Dartmouth CollegeORCID 0009-0004-4407-1932Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:biophysical modeling· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Alyssa M. RobertsiD· 1 shared Arminja Nadine KettenbachiD· 1 shared Christo Philip C. DragneviD· 1 shared Eugene DemidenkoiD· 1 shared F. W. KollingiD· 1 shared James V. AlvareziD· 1 shared Jonathan D. MarottiiD· 1 shared Kimberley S. SamkoeiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alyssa M. RobertsORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer ResearchPeer-reviewedJan 8, 2025

Endocrine persistence in ER+ breast cancer is accompanied by metabolic vulnerability in oxidative phosphorylation

Steven S. Tau, Mary Dickinson Chamberlin, Huijuan Yang…·Todd W. Miller

This study identifies mitochondrial oxidative phosphorylation as a metabolic vulnerability in endocrine-tolerant persister ER+ breast cancer cells, suggesting therapeutic targeting of mitochondrial function could prevent recurrence.

29 citationstop 1%

humanproteomics

𝕏 PostBluesky